CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MicroBrain Biotech develops microfluidic chips called Nerve-on-Chips to simulate neuron networks for biopharmaceutical research. This technology aims to reduce drug development costs and improve the accuracy of human-relevant drug responses, addressing the challenges posed by neurodegenerative diseases.
Neurodegenerative diseases (“ND”) are devastating as they cause individuals to lose their memories, independence, and ultimately, their lives.
In the absence of drugs able to cureor prevent start of ND, the latter are a human and financial burden for individual patients, their relativesthe health care system and society in general.
The worldwide economic impact of ND is evaluated at $2 trillion a year.
The incidence of ND is expected to grow in the coming few years as life expectancy increases.…
MICROBRAIN BIOTECH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
